Plasma Nitric Oxide Products Correlate with Cardiac Index of Congenital Heart Disease

2000 ◽  
Vol 21 (4) ◽  
pp. 378-381 ◽  
Author(s):  
J. Takaya ◽  
Y. Ikemoto ◽  
M. Teraguchi ◽  
S. Nogi ◽  
Y. Kobayashi
Keyword(s):  
Nitric Oxide ◽  
Congenital Heart Disease ◽  
Heart Disease ◽  
Cardiac Index ◽  
Congenital Heart

Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease

1996 ◽  
Vol 77 (7) ◽  
pp. 532-535 ◽  
Author(s):  
Michel Berner ◽  
Maurice Beghetti ◽  
Isabelle Spahr-Schopfer ◽  
Ingrid Oberhansli ◽  
Beat Friedli
Keyword(s):  
Nitric Oxide ◽  
Congenital Heart Disease ◽  
Pulmonary Hypertension ◽  
Heart Disease ◽  
Congenital Heart ◽  
Inhaled Nitric Oxide ◽  
Vascular Bed ◽  
Pulmonary Vascular Bed

scholarly journals Comparison of the Acute Pulmonary Vasodilating Effect of Beraprost Sodium and Nitric Oxide in Congenital Heart Disease

2005 ◽  
Vol 69 (1) ◽  
pp. 61-64 ◽  
Author(s):  
Kritvikrom Durongpisitkul ◽  
Duangmanee Laoprasitiporn ◽  
Thanarat Layangool ◽  
Rekwan Sittiwankul ◽  
Mannat Panamonta ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Beraprost Sodium ◽  
Vasodilating Effect

scholarly journals Very-low-dose inhaled nitric oxide: A selective pulmonary vasodilator after operations for congenital heart disease

1994 ◽  
Vol 108 (3) ◽  
pp. 487-494 ◽  
Author(s):  
O.I. Miller ◽  
D.S. Celermajer ◽  
J.E. Deanfield ◽  
D.J. Macrae
Keyword(s):  
Nitric Oxide ◽  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Low Dose ◽  
Inhaled Nitric Oxide ◽  
Pulmonary Vasodilator

Inhalation of Low-Dose Nitric Oxide to Evaluate Pulmonary Vascular Reactivity in Children with Congenital Heart Disease

1999 ◽  
Vol 20 (4) ◽  
pp. 278-282 ◽  
Author(s):  
T. Yasuda ◽  
N. Tauchi ◽  
R. Baba ◽  
K. Nishibata ◽  
T. Hatano ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Vascular Reactivity ◽  
Low Dose

Inhaled Nitric Oxide (INO) in Congenital Heart Disease (CHD) 105

1998 ◽  
Vol 43 ◽  
pp. 21-21
Author(s):  
Golde G Dudell ◽  
Margaret B Rennels ◽  
Michael E Pichichero
Keyword(s):  
Nitric Oxide ◽  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Inhaled Nitric Oxide

Beneficial effect of an oral analog of prostacyclin on pulmonary hypertension secondary to congenital heart disease

1998 ◽  
Vol 8 (2) ◽  
pp. 205-210 ◽  
Author(s):  
Fukiko Ichida ◽  
Kei-ichiro Uese ◽  
Shin-ichi Tsubata ◽  
Ikuo Hashimoto ◽  
Yuji Hamamichi ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Congenital Heart Disease ◽  
Pulmonary Hypertension ◽  
Heart Disease ◽  
Congenital Heart ◽  
Hemodynamic Effect ◽  
Pulmonary Vasodilation ◽  
Beraprost Sodium ◽  
Hypertension In Children ◽  
Appreciable Reduction

AbstractTo determine whether a newly synthesized oral analog of prostacyclin, called beraprost sodium, could cause pulmonary vasodilation, we studied its hemodynamic effect on pulmonary hypertension of children, comparing it to other vasodilatory agents, such as nitric oxide and tolazoline. We studied 20 children (mean age 24 months) having pulmonary hypertension secondary to congenital heart disease. A single oral dose of beraprost sodium resulted in an appreciable reduction of pulmonary vascular resistance (mean 34%), which was comparable to that induced by inhalation of nitric oxide and intravenous delivery of tolazoline (mean 41% and 31%, respectively). The results suggest that beraprost sodium may serve as a novel and safe vasodilator for the screening of pulmonary vasoreactivity, as well as the treatment of pulmonary hypertension in children.

scholarly journals Nitric oxide synthases in infants and children with pulmonary hypertension and congenital heart disease

2009 ◽  
Vol 10 (1) ◽  
Author(s):  
Thomas Hoehn ◽  
Brigitte Stiller ◽  
Allan R McPhaden ◽  
Roger M Wadsworth
Keyword(s):  
Nitric Oxide ◽  
Congenital Heart Disease ◽  
Pulmonary Hypertension ◽  
Heart Disease ◽  
Congenital Heart ◽  
Nitric Oxide Synthases ◽  
Infants And Children ◽  
In Infants And Children

Plasma levels of nitric oxide products and endothelin in pulmonary hypertension with congenital heart disease

2007 ◽  
Vol 87 (6) ◽  
pp. 715-716 ◽  
Author(s):  
Y Ikemoto ◽  
M. Teraguchi ◽  
J Takaya ◽  
S Nogi ◽  
Y. Kobayashi
Keyword(s):  
Nitric Oxide ◽  
Congenital Heart Disease ◽  
Pulmonary Hypertension ◽  
Heart Disease ◽  
Plasma Levels ◽  
Congenital Heart
Sign in / Sign up

Export Citation Format

Share Document